Friday, November 13, 2026
Get the IHR NewsletterSubscribe
› Rousselot

Nextida® NxCogni™

Targeted collagen peptide developed for cognitive well-being formulas.

Supplier: Rousselot. Positioned for: Brain & cognition. Company cites preclinical data, with open-label human data expected by December 2026 and two larger trials planned for 2027.

How to merchandise Nextida® NxCogni™

Where it sits

Brain and cognition section.

Pair it with

  • Omega-3 DHA
  • B vitamins
  • Lion's mane
  • Herbal teas

Who asks for it

Early adopters following new cognitive ingredients.

On the store floor

  • It is a new collagen peptide aimed at cognitive products.
  • Human research on it is still in progress, so set expectations honestly.
  • Ask what they currently take for focus to avoid duplicating products.

Display idea

Tag it 'new ingredient' and keep the research status visible on a card.

What a store can say about a product made with Nextida® NxCogni™ depends on that finished product's own licence or label in your market (for example a Health Canada NPN, US structure/function wording or EU authorised claims), so check it before describing uses.